Related references
Note: Only part of the references are listed.Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer's disease
Sophie Steeland et al.
EMBO MOLECULAR MEDICINE (2018)
Soluble TNFα Signaling within the Spinal Cord Contributes to the Development of Autonomic Dysreflexia and Ensuing Vascular and Immune Dysfunction after Spinal Cord Injury
Eugene Mironets et al.
JOURNAL OF NEUROSCIENCE (2018)
Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis
Sarah K. Williams et al.
SCIENTIFIC REPORTS (2018)
Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice
Kathryn P. MacPherson et al.
NEUROBIOLOGY OF DISEASE (2017)
Lovastatin Induces Neuroprotection Through Tumor Necrosis Factor Receptor 2 Signaling Pathways
Amalia M. Dolga et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Infliximab ameliorates AD-associated object recognition memory impairment
Dong Hyun Kim et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination
Pernille M. Madsen et al.
JOURNAL OF NEUROSCIENCE (2016)
Inhibiting tumor necrosis factor-α before amyloidosis prevent synaptic deficits in an Alzheimer's disease model
Chelsea Cavanagh et al.
NEUROBIOLOGY OF AGING (2016)
Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration
Yun Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
TNF-alpha G308A Polymorphism and the Susceptibility to Alzheimer's Disease: An Updated Meta-analysis
Tengfei Wang
ARCHIVES OF MEDICAL RESEARCH (2015)
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
Joseph Butchart et al.
NEUROLOGY (2015)
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Roman Fischer et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Central delivery of iodine-125-labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer's disease
Megan E. Roerink et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Associations of cytokine genes with Alzheimer's disease and depression in an elderly Korean population
Hee-Ju Kang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Astrocyte-Specific Activation of TNFR2 Promotes Oligodendrocyte Maturation by Secretion of Leukemia Inhibitory Factor
Roman Fischer et al.
GLIA (2014)
Genetic deletion of TNFRII gene enhances the Alzheimer-like pathology in an APP transgenic mouse model via reduction of phosphorylated IκBα
Hong Jiang et al.
HUMAN MOLECULAR GENETICS (2014)
Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease
Han-Yun Hsiao et al.
HUMAN MOLECULAR GENETICS (2014)
Altered Expression of Oligodendrocyte and Neuronal Marker Genes Predicts the Clinical Onset of Autoimmune Encephalomyelitis and Indicates the Effectiveness of Multiple Sclerosis-Directed Therapeutics
Maria Evangelidou et al.
JOURNAL OF IMMUNOLOGY (2014)
Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia
Bettina Hjelm Clausen et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in mice
Hans G. Novrup et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Peripheral administration of an anti-TNF-α receptor fusion protein counteracts the amyloid induced elevation of hippocampal TNF-α levels and memory deficits in mice
E. R. Detrait et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro® 1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian Rats
Christopher J. Barnum et al.
JOURNAL OF PARKINSONS DISEASE (2014)
Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System
P. Deepak et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress
Olaf Maier et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS
Jigisha R. Patel et al.
ACTA NEUROPATHOLOGICA (2012)
Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination
Roberta Brambilla et al.
BRAIN (2011)
Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-κB
Era Taoufik et al.
BRAIN (2011)
Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains
Jian-Quan Shi et al.
BRAIN RESEARCH (2011)
Tumor necrosis factor receptor cross-talk
Petrus J. W. Naude et al.
FEBS JOURNAL (2011)
COGNITIVE IMPROVEMENT WITH INTRATHECAL ADMINISTRATION OF INFLIXIMAB IN A WOMAN WITH ALZHEIMER'S DISEASE
Jian-Quan Shi et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Autoimmune-like syndromes during TNF blockade: does infection have a role?
Joerg C. Prinz
NATURE REVIEWS RHEUMATOLOGY (2011)
A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell Death
Roman Fischer et al.
PLOS ONE (2011)
Differential Activation of Tumor Necrosis Factor Receptors Distinguishes between Brains from Alzheimer's Disease and Non-Demented Patients
Xin Cheng et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Soluble TNF, but not membrane TNF, is critical in LPS-induced hepatitis
Maria L. Olleros et al.
JOURNAL OF HEPATOLOGY (2010)
ATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibody
Kirstin A. Zettlitz et al.
MABS (2010)
Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration
Edward L. Tobinick et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice
Ping He et al.
JOURNAL OF CELL BIOLOGY (2007)
Inflammatory markers and the risk of Alzheimer disease - The Framingham study
Z. S. Tan et al.
NEUROLOGY (2007)
Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease
Anton Alvarez et al.
NEUROBIOLOGY OF AGING (2007)
Microglial phagocytosis induced by fibrillar β-amyloid and IgGs are differentially regulated by proinflammatory cytokines
J Koenigsknecht-Talboo et al.
JOURNAL OF NEUROSCIENCE (2005)
Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system
G Eissner et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation -: Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-κB pathway
L Marchetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Signalling pathways of the TNF superfamily: A double-edged sword
BB Aggarwal
NATURE REVIEWS IMMUNOLOGY (2003)
The induction of the TNFα death domain signaling pathway in Alzheimer's disease brain
M Zhao et al.
NEUROCHEMICAL RESEARCH (2003)
Tumor necrosis factor signaling
H Wajant et al.
CELL DEATH AND DIFFERENTIATION (2003)
Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: Opposite roles of TNF receptor 1 and TNF receptor 2
V Fontaine et al.
JOURNAL OF NEUROSCIENCE (2002)
TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2
XM Li et al.
NATURE (2002)
Onset of multiple sclerosis associated with anti-TNF therapy
NL Sicotte et al.
NEUROLOGY (2001)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4(+) T cells
S Harashima et al.
JOURNAL OF IMMUNOLOGY (2001)
Costimulatory effects of interferon-γ and interleukin-1β or tumor necrosis factor α on the synthesis of aβ1-40 and aβ1-42 by human astrocytes
I Blasko et al.
NEUROBIOLOGY OF DISEASE (2000)
Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages
G Eissner et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
